Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Functional evidence for the presence of tumor suppressor gene on chromosome 10p15 in human prostate cancers

Abstract

Loss of heterozygosity on chromosome 10p was observed frequently in human prostate cancers. Studies have demonstrated that the introduction of the short arm of human chromosome 10 into a human prostate cancer cell line, PPC-1, by microcell-mediated chromosome transfer (MMCT), suppressed the malignant phenotype, suggesting the presence of a prostate tumor suppressor gene(s) within a region of 17 cM at distal 10p. To narrow down the candidate region harboring the tumor suppressor gene, a series of 10p fragments were transferred into PPC-1 cells by MMCT using a panel of hamster–human hybrid cells containing various portions of 10p. Four of the six hybrid cells obtained showed decreased tumorigenicity when injected subcutaneously into athymic nude mice. Tumors developed only at six of 40 injection sites for these four hybrid cells. In contrast, the other two hybrid cells, as well as parental PPC-1 cells, were judged to be fully tumorigenic because tumors appeared at a total 26 of 32 sites for the two hybrid cells and 15 of 16 sites for PPC-1. Allelotyping of 10p combined with fluorescence in situ hybridization in these hybrid cells suggested that a prostate tumor suppressor gene was located within a fragment of approximately 1.2 Mb flanked by D10S1172 and D10S226 on 10p15.1.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Albertsen H, Plaetke R, Ballard L, Fujimoto E, Connolly J, Lawrence E, Rodriguez P, Robertson M, Bradley P, Milner B, Fuhrman D, Marks A, Sargent R, Cartwright P, Matsunami N and White R. . 1994 Am. J. Hum. Genet. 54: 516–525.

  • Bergerheim USR, Kunimi K, Collins P and Ekman P. . 1991 Genes Chrom. Cancer 3: 215–220.

  • Blin N and Stafford DM. . 1976 Nucleic Acids Res. 3: 2303–2308.

  • Bova GS, Carter BS, Bussemakers MJ, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC and Isaacs WB. . 1993 Cancer Res. 53: 3869–3873.

  • Brothman AR, Lesho LJ, Somers KD, Wright Jr GL and Merchant DJ. . 1989 Int. J. Cancer 44: 898–903.

  • Brothman AR, Peehl DM, Patel AM and McNeal JE. . 1990 Cancer Res. 50: 3795–3803.

  • Brothman AR, Wilkins PC, Sales EW and Somers KD. . 1991 J. Urol. 145: 1088–1091.

  • Brothman AR and Patel AM. . 1992 Cytogenet. Cell Genet. 60: 8–11.

  • Brothman AR, Steele MR, Williams BJ, Jones E, Odelberg S, Albertsen HM, Jorde LB, Rohr LR and Stephenson RA. . 1995 Genes Chromosomes Cancer 13: 278–284.

  • Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI and Isaacs WB. . 1990 Proc. Natl. Acad. Sci. USA 87: 8751–8755.

  • Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT and Barrett JC. . 1995 Science 268: 884–886.

  • Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB and Prochownik EV. . 1995 Nat. Genet. 9: 249–255.

  • Effert PJ, Neubauer A, Walther PJ and Liu ET. . 1992 J. Urol. 147: 789–793.

  • Fournier REK. . 1981 Proc. Natl. Acad. Sci. USA 78: 6349–6353.

  • Gao AC, Lou W, Ichikawa T, Denmeade SR, Barrett JC and Isaacs JT. . 1999 The Prostate 38: 46–54.

  • Ichikawa T, Ichikawa Y, Dong J, Hawkins AL, Griffin CA, Isaacs WB, Oshimura M, Barrett JC and Isaacs JT. . 1992 Cancer Res. 52: 3486–3490.

  • Ichikawa T, Nihei N, Suzuki H, Oshimura M, Emi M, Nakamura Y, Hayata I, Isaacs JT and Shimazaki J. . 1994 Cancer Res. 54: 2299–2302.

  • Isaacs WB, Carter BS and Ewing CM. . 1991 Cancer Res. 51: 4716–4720.

  • Ittmann M. . 1996 Cancer Res. 56: 2143–2147.

  • Kawana Y, Komiya A, Ueda T, Nihei N, Kuramochi H, Suzuki H, Yatani R, Imai T, Dong JT, Imai T, Yoshie O, Barrett JC, Isaacs JT, Shimazaki J, Ito H and Ichikawa T. . 1997 Prostate 32: 205–213.

  • Kimmelman AC, Ross DA and Liang BC. . 1996 Genomics 34: 250–254.

  • Koi M, Johnson LA, Kalikin LM, Little PFR, Nakamura Y and Feinberg AP. . 1993 Science 260: 361–364.

  • Kon H, Sonoda Y, Kumabe T, Yoshimoto T, Sekiya T and Murakami Y. . 1998 Oncogene 16: 257–263.

  • Kunimi K, Bergerheim USR, Larsson IL, Ekman P and Collins VP. . 1991 Genomics 11: 530–536.

  • Landis SH, Murray T, Bolden S and Wingo PA. . 1998 CA Cancer J. Clin. 49: 8–31.

  • Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH and Parsons R. . 1997 Science 275: 1943–1947.

  • MacGrogan D, Levy A, Bostwick D, Wagner M, Wells D and Bookstein R. . 1994 Genes Chrom. Cancer 10: 151–159.

  • Macoska JA, Micale MA, Sakr WA, Benson PD and Wolman SR. . 1993 Genes Chrom. Cancer 8: 88–97.

  • Murakami YS, Brothman AR, Leach RJ and White RL. . 1995 Cancer Res. 55: 3389–3394.

  • Murakami YS, Albertsen H, Brothman AR, Leach RJ and White RL. . 1996 Cancer Res. 56: 2157–2160.

  • Murakami Y, Nobukuni T, Tamura K, Maruyama T, Sekiya T, Arai Y, Gomyou H, Tanigami A, Ohki M, Cabin D, Frischmeyer P, Hunt P and Reeves RH. . 1998 Proc. Natl. Acad. Sci. USA 95: 8153–8158.

  • Murakami Y, Uejima H, Fukuhara H, Maruyama T, Oshimura M and Sekiya T. . 2000 J. Hum. Genet. in press.

  • Nihei N, Ichikawa T, Kawana Y, Kuramochi H, Kugo H, Oshimura M, Killary AM, Rinker-Schaeffer CW, Barrett JC, Isaacs JT and Shimazaki J. . 1995 Genes Chrom. Cancer 14: 112–119.

  • Nihei N, Ichilkawa T, Kawana Y, Kuramochi H, Kugoh H, Oshimura M, Hayata I, Shimazaki J and Ito H. . 1996 Genes Chrom. Cancer 17: 260–268.

  • Nihei N, Ohta S, Kuramochi H, Kugoh H, Oshimura M, Barrett JC, Isaacs JT, Igarashi T, Ito H, Masai M, Ichikawa Y and Ichikawa T. . 1999 Genes Chrom. Cancer 24: 1–8.

  • Pershouse MA, Stubblefield E, Hadi A, Killary AM, Yung WKA and Steck PA. . 1993 Cancer Res. 53: 5043–5050.

  • Phillips SM, Morton DG, Lee SJ, Wallace DM and Neoptolemos JP. . 1994 Br. J. Urol. 73: 390–395.

  • Pinkel D, Straume T and Gray JW. . 1986 Proc. Natl. Acad. Sci. USA 83: 2934–2938.

  • Rinker-Schaeffer CW, Hawkins AL, Ru N, Dong J, Stoica G, Griffin CA, Ichikawa T, Barrett JC and Isaacs JT. . 1994 Cancer Res. 54: 6249–6256.

  • Robertson GP, Herbst RA, Nagane M, Huang HJS and Cavenee WK. . 1999 Cancer Res. 59: 3596–3601.

  • Sanchez Y, Lovell M, Marin MC, Wong PE, Wolf-Ledbetter ME, McDonnell TJ and Killary AM. . 1996 Proc. Natl. Acad. Sci. 93: 2551–2556.

  • Shimura M, Onozuka Y, Yamaguchi T, Hatake K, Takaku F and Ishizaka Y. . 1999 Cancer Res. 59: 2259–2264.

  • Sonoda Y, Murakami Y, Tominaga T, Kayama T, Yoshimoto T and Sekiya T. . 1996 Jpn. J. Cancer Res. 87: 363–367.

  • Steck PA, Ligon AH, Cheong P, Yung WKA and Pershouse MA. . 1995 Genes Chrom. Cancer 12: 255–261.

  • Tanaka K, Oshimura M, Kikuchi R, Seki M, Hayashi T and Miyaki M. . 1991 Nature 349: 340–342.

  • Trybus TM, Burgess AC, Wojno KJ, Glover TW and Macoska JA. . 1996 Cancer Res. 56: 2263–2267.

  • Visakorpi T, Kallioniemi A, Hyytinen E, Karhu R, Tammela T, Isola J and Kallioniemi O. . 1995 Cancer Res. 55: 342–347.

  • Weissman BE, Saxon PJ, Pasquale SR, Jones GR, Geiser AG and Stanbridge EJ. . 1987 Science 236: 175–180.

Download references

Acknowledgements

We thank Dr Arthur R Brothman for providing PPC-1 cells and Dr Raymond L White for valuable comments and suggestions. This work was supported in part by a Grant-in Aid for the Second Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health and Welfare, Japan; and by a Grant-in-Aid for Special Projects for Cancer Research from the Ministry of Education, Science, Sports and Culture of Japan. H Fukuhara is a recipient of Research Resident Fellowships from the Foundation for Promotion of Cancer Research of Japan.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fukuhara, H., Maruyama, T., Nomura, S. et al. Functional evidence for the presence of tumor suppressor gene on chromosome 10p15 in human prostate cancers. Oncogene 20, 314–319 (2001). https://doi.org/10.1038/sj.onc.1204079

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204079

Keywords

This article is cited by

Search

Quick links